Panagora Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Panagora Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-9,791	Closed	-$16K	–	2622
2017 Q2	$16K	Sell	9,791 -1	-0%	-$2	﹤0.01%	2326
2017 Q1	$33K	Sell	9,792 -5,962	-38%	-$28.2K	﹤0.01%	2087
2016 Q4	$82K	Buy	15,754 +12,445	+376%	+$215K	﹤0.01%	2006
2016 Q3	$83K	Buy	+3,309	New	+$83.5K	﹤0.01%	2016
2016 Q1	–	Sell	-1,668	Closed	-$62K	–	2381
2015 Q4	$62K	Buy	1,668 +1,049	+169%	+$46.3K	﹤0.01%	1924
2015 Q3	$30K	Buy	619 +2	+0.3%	+$140	﹤0.01%	2085
2015 Q2	$43K	Buy	+617	New	+$28.6K	﹤0.01%	2176

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Panagora Asset Management's ANTH Position: Q3 2017 in Review

Panagora Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2017, closing a stake of 9,791 shares — an estimated $16K sold.

Panagora Asset Management first reported a position in ANTH in Q2 2015 and held it in 7 quarters. The position peaked at $83K in Q3 2016. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2017.

Panagora Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Panagora Asset Management sold 9,791 Anthera Pharmaceuticals, Inc. shares in Q3 2017, an estimated $16K.
Panagora Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
Panagora Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $83K in Q3 2016.
35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2017.

Based on Panagora Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.